EUVIMEDEUVIMED entdecken
Crossref

Isoimperatorin attenuates renal ischemia-reperfusion injury by targeting DLAT-associated cuproptosis

Jiqiang Zhao, Jiquan Zhao, Junlei Ma, Juan Peng, Li Zhao

The International Journal of Biochemistry & Cell Biology · 2026-11 · 107072

DOI: 10.1016/j.biocel.2026.107072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2026-11. Verfasst von Jiqiang Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organ Transplantation, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, Guangdong Province, China. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a copper-dependent form of regulated cell death, has recently been implicated in the pathogenesis of renal ischemia-reperfusion injury (IRI). Isoimperatorin (ISO), a natural coumarin, possesses nephroprotective properties, yet its effect on cuproptosis remains unknown. Herein, this study demonstrated that ISO administration effectively attenuated renal tubular injury, improved renal function, and reduced copper accumulation in a mouse IRI model. In vitro, ISO alleviated hypoxia/reoxygenation-induced oxidative stress, mitochondrial damage, and cuproptosis susceptibility. Single-cell transcriptomic (scRNA-Seq) analysis revealed that cuproptosis-related genes (e.g. Fdx1 and Slc31a1) exhibited transcriptional alterations. Through RNA sequencing and molecular interaction assays, this research identified dihydrolipoamide S-acetyltransferase (DLAT) as a binding partner of ISO. DLAT overexpression attenuated the protective effects of ISO, whereas the copper chelator tetrathiomolybdate (TTM) partially recapitulated its action. In vivo, ISO and TTM both suppressed IRI-induced DLAT, FDX1, and CTR1 upregulation. Collectively, our findings suggest that ISO attenuates cuproptosis susceptibility through DLAT, providing a mechanistic rationale for targeting the copper-DLAT axis in ischemic kidney injury.

Schlagwörter

Stichwörter der Autor:innen

CuproptosisDLATrenal ischemia-reperfusion injury

Autor:innen und Institutionen

  • Department of Organ Transplantation, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, Guangdong Province, China.
  • Department of Urological Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University (Shenzhen Futian), Shenzhen 518033, Guangdong Province, China. Electronic address: zhaojiqiang_gzmu@yeah.net.
  • Department of Pathology, the Third Affiliated Hospital of Guangzhou Medical University. Guangzhou 510150, China.

Zitieren

APA

Zhao, J., Zhao, J., Ma, J., Peng, J., & Zhao, L. (2026). Isoimperatorin attenuates renal ischemia-reperfusion injury by targeting DLAT-associated cuproptosis. The International Journal of Biochemistry & Cell Biology, 107072. https://doi.org/10.1016/j.biocel.2026.107072

Vancouver

Zhao J, Zhao J, Ma J, Peng J, Zhao L. Isoimperatorin attenuates renal ischemia-reperfusion injury by targeting DLAT-associated cuproptosis. The International Journal of Biochemistry & Cell Biology. 2026:107072. doi:10.1016/j.biocel.2026.107072

BibTeX
@article{Zhao2026,
  author = {Zhao, Jiqiang and Zhao, Jiquan and Ma, Junlei and Peng, Juan and Zhao, Li},
  title = {Isoimperatorin attenuates renal ischemia-reperfusion injury by targeting DLAT-associated cuproptosis},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2026},
  pages = {107072},
  doi = {10.1016/j.biocel.2026.107072}
}
Kostenlos starten →